Patents by Inventor Henry Trong Le

Henry Trong Le has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FERRIC CITRATE DOSAGE FORMS
    Publication number: 20200297689
    Abstract: The disclosure relates to ferric citrate tablets and dosage forms.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 24, 2020
    Inventor: Henry Trong Le
  • FERRIC CITRATE DOSAGE FORMS
    Publication number: 20200215019
    Abstract: The disclosure relates to ferric citrate tablets and dosage forms.
    Type: Application
    Filed: April 5, 2019
    Publication date: July 9, 2020
    Inventor: Henry Trong Le
  • Ferric citrate dosage forms
    Patent number: 10300039
    Abstract: Disclosed herein are ferric citrate-containing tablets. In various embodiments, the tablets include ferric citrate formulations that meet certain dissolution, tableting and disintegration standards. In various aspects, the tablet formulations can include ferric citrate as the active ingredient and a binder. The formulations also can include a lubricant and/or a disintegrant (which, in some embodiments, can be the same as the binder).
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: May 28, 2019
    Assignee: KERYX BIOPHARMACEUTICALS, INC.
    Inventor: Henry Trong Le
  • FERRIC CITRATE DOSAGE FORMS
    Publication number: 20160263075
    Abstract: The disclosre relates to ferric citrate tablets and dosage forms.
    Type: Application
    Filed: May 19, 2016
    Publication date: September 15, 2016
    Applicant: KERYX BIOPHARMACEUTICALS, INC.
    Inventor: Henry Trong Le
  • Ferric citrate dosage forms
    Patent number: 9387191
    Abstract: Disclosed herein are ferric citrate-containing tablets. In various embodiments, the tablets include ferric citrate formulations that meet certain dissolution, tableting and disintegration standards. In various aspects, the tablet formulations can include ferric citrate as the active ingredient and a binder. The formulations also can include a lubricant and/or a disintegrant (which, in some embodiments, can be the same as the binder).
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: July 12, 2016
    Assignee: Keryx Biopharmaceuticals, Inc.
    Inventor: Henry Trong Le
  • FERRIC CITRATE DOSAGE FORMS
    Publication number: 20130274328
    Abstract: Disclosed herein are ferric citrate-containing tablets. In various embodiments, the tablets include ferric citrate formulations that meet certain dissolution, tableting and disintegration standards. In various aspects, the tablet formulations can include ferric citrate as the active ingredient and a binder. The formulations also can include a lubricant and/or a disintegrant (which, in some embodiments, can be the same as the binder).
    Type: Application
    Filed: June 7, 2013
    Publication date: October 17, 2013
    Inventor: Henry Trong Le
  • FERRIC CITRATE DOSAGE FORMS
    Publication number: 20120115945
    Abstract: The disclosure relates to ferric citrate tablets and dosage forms.
    Type: Application
    Filed: July 21, 2010
    Publication date: May 10, 2012
    Applicant: Keryx Biopharmaceuticals Inc.
    Inventor: Henry Trong Le